Inova Lands $50M Gift for Personalized Oncology Research
News May 27, 2015
Inova recently announced a $50 million gift from Dwight Schar to launch a new oncology research institute at the Inova Center for Personalized Health in Fairfax, Virginia.
Donald "Skip" Trump will lead the cancer institute as CEO and executive director, Inova said.
The Inova Center for Personalized Health is part of the Inova Health System, a non-profit healthcare provider in Northern Virginia and the Washington, DC metro area. The Inova Translational Medicine Institute is also a part of the Inova system.
In a separate statement, the Fairfax County Economic Development Authority said that the new institute has as its goal, the creation of a leading center for translational cancer research and patient care based on genomics and individualized therapy. Researchers at the institute will develop new genomics-based tests, therapies, and population health processes. The institute will also collaborate with life science firms, resulting in the expansion of the life science economy in the Virginia and Washington region.
In April 2014, Inova announced it planned to offer whole-genome sequencing by prescription for sick newborns.
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
Computer Program Helps Find Ways to Repurpose Existing DrugsNews
Researchers have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, matches existing data about FDA-approved drugs to diseases, and predicts potential drug efficacy.READ MORE
Prostate- and Colon Cancer Targeted With Tapeworm DrugNews
Recently researchers found that a substance in medicine against parasites like Giardia and Tapeworms, acts like tailored medicine against prostate- and colon cancer.READ MORE